In order to quickly freeze and then temporarily store blood plasma or biological samples to a core temperature below -30°C in less than an hour, contact shock freezers are used.
The fresh frozen plasma, red blood cells, and platelet concentrates are stored safely in the plasma freezer by providing and maintaining freezing temperature at -30 or -40 °C. The operating temperature of a refrigerator and a freezer is what distinguishes them from one another. The Safety Standards were created to specify some important technical aspects of a product.
The Global Plasma Contact Shock Freezers market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
Plasma contact Shock Freezers are developed for quickly freezing biological and pharmaceutical products to a core temperature of -30°C, including blood plasma. The CSF61 and CSF101 Contact Shock Freezers from B Medical Systems are made to quickly freeze blood plasma, biological samples, and pharmaceutical preparations to a core temperature of -30°C.
In addition, great effort has been taken to ensure that all models are energy efficient, which will further serve the interests of the customer in the long run from an operating standpoint. Blood banks and blood transfusion facilities can use plasma contact shock freezers to quickly freeze plasma in accordance with medical requirements.
With the largest model being able to cool down 48 bags of 350ml to a core temperature below -30°C in less than 30 minutes, they offer one of the fastest freezing periods on the market. Both variants, CSF 61 and CSF 101, are classified as medical devices Class II(a) and approved as complying with AABB criteria.
They both rely on a special technology. A 40-year career in medical refrigeration, including more than 15 years of contact shock freezing experience, went into the creation of this patent-pending technological advancement.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.